<DOC>
	<DOCNO>NCT00892762</DOCNO>
	<brief_summary>The purpose study understand difference visual function-related patient-reported outcome non-BAK medication ( Travoprost APS ) BAK-preserved medication ( XALATAN® ) patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Travoprost APS Versus Xalatan® Patient Reported Outcomes Ocular Surface Health</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Must clinical diagnosis openangle glaucoma ( without pseudoexfoliation pigment dispersion component ) , ocular hypertension least 1 eye . Must willing able discontinue use topical ocular medication study medication duration study . Must Intraocular Pressure ( IOP ) control monotherapy use XALATAN® least 1 continuous month prior Visit 1 . Women childbearing potential must meet following condition Visit 1 : They breastfeed . They negative urine pregnancy test Visit 1 . They agree undertake urine pregnancy test upon enter exit study . They plan become pregnant course study . They currently use , agree use adequate birth control method duration study . Other protocolspecified inclusion criterion may apply . Any abnormality prevent reliable applanation tonometry study eye ( ) . Presence ocular pathology either eye see slit lamp fundus exam , opinion Investigator may preclude safe administration test article safe participation study . Dry eye keratoconjunctivitis sicca ( KCS ) , currently , treat use punctal plug , punctal cautery , Restasis® , topical ocular corticosteroid . Patients undergone keratorefractive ocular laser procedure , corneal surgery surgery corneal surface , include limited LASIK PRK , within 6 month prior Visit 1 . Patients undergone intraocular extraocular surgery , either eye , within 6 month prior Visit 1 . Any history ocular infection inflammatory ocular condition within past 3 month either eye . Use systemic medication chronic basis stable dose regimen least 30 day prior Visit 1 . Use ocular medication XALATAN® within 7 day Visit 1 . Use corticosteroid within 30 day Visit 1 . Use contact lens within 30 day Visit 1 . Concomitant use contact lenses also exclude duration study . History intolerance hypersensitivity component test article . Participation investigational drug device study within 30 day enter study . History evidence corneal transplant transplant variant procedure . Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Open Angle Glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>OAG</keyword>
	<keyword>OH</keyword>
</DOC>